Trial intelligence / Profile preview

Clinical trial evaluating natural progesterone supplements for prevention of preterm twin birth

2004-004136-31Phase 3Completed

Sponsor
Laboratorios Effik
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of progesterone in preterm birth (3 arms), sponsored by Laboratorios Effik. Primary endpoint: Global prematurity rate (<37 weeks). Started May 2006; status: completed.

02

Drugs

progesterone
03

Conditions

preterm birth

Beyond the preview

Go deeper on 2004-004136-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004136-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call